These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR. Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857 [Abstract] [Full Text] [Related]
3. Introduction: combination antiviral therapy in chronic hepatitis C. Sherlock S. J Hepatol; 1995 Feb; 23 Suppl 2():1-2. PubMed ID: 8720285 [No Abstract] [Full Text] [Related]
4. I favor therapy for hepatitis C virus recurrence after transplantation. Samuel D. Liver Transpl; 2002 Oct; 8(10 Suppl 1):S55-8. PubMed ID: 12362300 [No Abstract] [Full Text] [Related]
5. [Should we treat cirrhosis in hepatitis C carriers with antiviral agents?]. Brenard R, Closon ML, Fevery J, Hautekeete M. Rev Med Brux; 1999 Feb; 20(1):A50. PubMed ID: 10091538 [No Abstract] [Full Text] [Related]
6. [The course of hepatitis C infection after liver transplantation]. Ołdakowska-Jedynak U, Paczek L. Pol Merkur Lekarski; 2005 Aug; 19(110):220-4. PubMed ID: 16245439 [Abstract] [Full Text] [Related]
7. Relapse response to interferon and ribavirin in liver transplant recipient with hepatitis C recurrence. Coccoli P, Cordone G, Bruno M, Parrilli G. Transplant Proc; 2005 Dec; 37(10):4406-7. PubMed ID: 16387132 [Abstract] [Full Text] [Related]
9. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon. Di Bisceglie AM, Thompson J, Smith-Wilkaitis N, Brunt EM, Bacon BR. Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751 [Abstract] [Full Text] [Related]
10. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C. Fernández I, Ulloa E, Colina F, Abradelo M, Jiménez C, Gimeno A, Meneu JC, Lumbreras C, Solís-Herruzo JA, Moreno E. Liver Transpl; 2009 Aug; 15(8):948-55. PubMed ID: 19642125 [Abstract] [Full Text] [Related]
14. Ribavirin in the treatment of recurrent hepatitis C after liver transplantation: difficult to manage but essential for success. Samuel D, Roche B. J Hepatol; 2007 Jun; 46(6):988-91. PubMed ID: 17445936 [No Abstract] [Full Text] [Related]
16. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Feld JJ, Hoofnagle JH. Nature; 2005 Aug 18; 436(7053):967-72. PubMed ID: 16107837 [Abstract] [Full Text] [Related]
17. Recurrence of hepatitis C after liver transplantation. Friman S. Transplant Proc; 2005 Oct 18; 37(8):3311-2. PubMed ID: 16298582 [Abstract] [Full Text] [Related]